The authors observed that microglia lacking SYK activation could not encapsulate Aβ plaques accelerating AD pathology and cognitive deficits and demonstrated that immunotherapies boosting SYK through C-Type Lectin Domain Containing 7A (CLEC7A) improved microglia activation [154]. This evidence concerns the gene CLEC7A and Alzheimer disease.